2022-11-29 Exercise | 2022-11-30 4:42 pm | N/A 2023-10-07 | Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner | 7,176 | $0 | 1,226,412 (Indirect) | View |
2022-11-29 Exercise | 2022-11-30 4:42 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner | 7,176 | $0.0001 | 1,226,412 (Indirect) | View |
Ownership(A) | 2022-11-30 4:37 pm | N/A 2023-10-07 | Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner | 0 | $0 | 7,176 (Indirect) | View |
2020-05-20 Option Award | 2020-05-22 4:10 pm | N/A 2030-05-20 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |
2020-04-13 Conversion | 2020-04-13 5:18 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner | 3,545,100 | $0 | 149,262 (Indirect) | View |
Ownership | 2020-04-07 8:14 pm | N/A N/A | Keros Therapeutics Inc. | KROS | Pontifax Management 4 G.P. (2015) Ltd. Pontifax (Israel) IV L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax Late Stage Fund L.P. Pontifax Late Stage GP Ltd. 10% Owner | 0 | $0 | 4,297,008 (Indirect) | View |
2019-11-13 Conversion | 2019-11-13 7:10 pm | N/A N/A | 89bio Inc. | ETNB | Kariv Tomer Pontifax (Israel) V L.P. Pontifax (Cayman) V L.P. Pontifax (China) V L.P. Pontifax 5 G.P. L.P. Pontifax Management 4 G.P. (2015) Ltd. Pontifax Late Stage GP Ltd. Pontifax Late Stage Fund L.P. Director 10% Owner | 6,384,672 | $0 | 1,134,671 (Indirect) | View |
Ownership | 2019-11-08 7:17 pm | N/A N/A | 89bio Inc. | ETNB | Kariv Tomer Pontifax (Israel) V L.P. Pontifax (Cayman) V L.P. Pontifax (China) V L.P. Pontifax 5 G.P. L.P. Pontifax Management 4 G.P. (2015) Ltd. Director 10% Owner | 0 | $0 | 884,671 (Indirect) | View |
2019-05-29 Option Award | 2019-05-29 5:15 pm | N/A 2029-05-29 | Eloxx Pharmaceuticals Inc. | ELOX | Pontifax Management 4 G.P. (2015) Ltd. Pontifax IV GP L.P. Pontifax (Cayman) IV L.P. Pontifax (China) IV L.P. Pontifax (Israel) IV L.P. Pontifax Management III G.P. (2011) Ltd. Pontifax Management Fund III L.P. Pontifax (Cayman) III L.P. Pontifax (Israel) III L.P. 10% Owner | 40,000 | $0 | 40,000 (Indirect) | View |